Key result
Intracardiac echocardiography-guided left atrial appendage closure within zero-fluoroscopy catheter ablation was safe, with a 3.6% procedure-related adverse event rate and no ischemic strokes.
Why the study?
Simultaneous AF catheter ablation and LAAC are sometimes recommended, but the advantages of ICE guidance for this combined procedure have been scarcely reported.
Is intracardiac echocardiography-guided left atrial appendage closure within a zero-fluoroscopy atrial fibrillation ablation procedure safe and effective in patients with symptomatic AF?
Cohort (n=56)
Is intracardiac echocardiography-guided left atrial appendage closure within a zero-fluoroscopy atrial fibrillation ablation procedure safe and effective in patients with symptomatic AF?
ICE-guided LAAC combined with zero-fluoroscopy AF ablation is technically feasible and safe, allowing for high rates of oral anticoagulant discontinuation without increasing stroke or bleeding risks.
Supports feasibility of combined ICE-guided LAAC and zero-fluoroscopy AF ablation; leaves open need for randomized trials before practice change.
Background Simultaneous atrial fibrillation (AF) catheter ablation and left atrial appendage closure (LAAC) are sometimes recommended for both rhythm control and stroke prevention. However, the advantages of intracardiac echocardiography (ICE) guidance for this combined procedure have been scarcely reported. We aim to evaluate the clinical outcomes and safety of ICE‐guided LAAC within a zero‐fluoroscopy catheter ablation procedure. Methods and Results From April 2019 to April 2020, 56 patients with symptomatic AF underwent concomitant catheter ablation and LAAC. ICE with a multi‐angled imaging protocol mimicking the TEE echo windows was used to guide LAAC. Successful radiofrequency catheter ablation and LAAC were achieved in all patients. Procedure‐related adverse event rate was 3.6%. During the 12‐month follow‐up, 75.0% of patients became free of arrhythmia recurrences and oral anticoagulants were discontinued in 96.4% of patients. No ischemic stroke occurred despite two cases of device‐related thrombosis versus an expected stroke rate of 4.8% based on the CHA 2 DS 2 ‐VASc score. The overall major bleeding events rate was 1.8%, which represented a relative reduction of 68% versus an expected bleeding rate of 5.7% based on the HAS‐BLED score of the patient cohort. The incidence of iatrogenic atrial septal defect secondary to single transseptal access dropped from 57.9% at 2 months to 4.2% at 12 months TEE follow‐up. Conclusion The combination of catheter ablation and LAAC under ICE guidance was safe and effective in AF patients with high stroke risk. ICE with our novel protocol was technically feasible for comprehensive and systematic assessment of device implantation.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2022) conducted a cohort in Symptomatic atrial fibrillation (n=56). Intracardiac echocardiography-guided left atrial appendage closure within zero-fluoroscopy catheter ablation was evaluated on Procedure-related adverse events. Intracardiac echocardiography-guided left atrial appendage closure within zero-fluoroscopy catheter ablation was safe, with a 3.6% procedure-related adverse event rate and no ischemic strokes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: